MENU
+Compare
CMMB
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$2.64
Change
+$0.14 (+5.60%)
Capitalization
13.7M

CMMB Chemomab Therapeutics Ltd Forecast, Technical & Fundamental Analysis

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more

Industry: #Biotechnology
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CMMB with price predictions
Sep 26, 2025

CMMB in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 17, 2025

CMMB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where CMMB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CMMB's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for CMMB just turned positive on September 26, 2025. Looking at past instances where CMMB's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CMMB advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMMB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CMMB entered a downward trend on September 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.413) is normal, around the industry mean (19.823). P/E Ratio (0.000) is within average values for comparable stocks, (53.778). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.098). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (349.540).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CMMB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CMMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CMMB is expected to report earnings to fall 68.75% to 0 cents per share on November 07

Chemomab Therapeutics Ltd CMMB Stock Earnings Reports
Q3'25
Est.
$0.00
Q2'25
Beat
by $0.08
Q1'25
Est.
$-0.01
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.07
The last earnings report on August 14 showed earnings per share of -1 cents, beating the estimate of -10 cents. With 288.49K shares outstanding, the current market capitalization sits at 13.70M.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Kiryat Atidim
Phone
+972 773310156
Employees
20
Web
https://www.chemomab.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSTI11.970.32
+2.75%
SoundThinking
NBY2.190.05
+2.34%
NovaBay Pharmaceuticals
BWMN42.080.21
+0.50%
Bowman Consulting Group Ltd
WNS76.170.03
+0.04%
WNS (Holdings) Limited
STM28.00-0.30
-1.06%
STMicroelectronics NV

CMMB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with HURA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then HURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
+5.60%
HURA - CMMB
34%
Loosely correlated
+0.41%
FATE - CMMB
32%
Poorly correlated
+3.01%
RXRX - CMMB
32%
Poorly correlated
+1.94%
AURA - CMMB
31%
Poorly correlated
+4.76%
TSHA - CMMB
31%
Poorly correlated
+6.21%
More